Newly Diagnosed Archives

January 13, 2023

Dr. Shahzad Mustafa on What it Means to be Immunocompromised for Patients with CLL/SLL

\In this interview, Dr. Brian Koffman spoke with Dr. Shahzad Mustafa, Division Chief of Allergy, Immunology, and Rheumatology at Rochester Regional Health and Clinical Associate Professor of Medicine at the University of Rochester School of Medicine and Dentistry. They discussed immune deficiency (a.k.a. being immunocompromised) and what that means

December 29, 2022

What Makes Being Diagnosed with CLL So Surprising

Dr. Koffman was interviewed by Prevention magazine to share some of his emotional experiences when he was diagnosed with chronic lymphocytic leukemia in 2005 and what he learned that helped him cope, primarily through the early part of his journey when he was asked to “Watch and Wait.” The

December 29, 2022

EAT THIS, NOT THAT! Signs There May Be Something Wrong with Your Blood, Including Weight Loss

While the questions were about blood disorders in general and not chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) or even leukemias specifically, you might find my responses and those of Dr. Eric Tam helpful in developing a broader understanding of what can go wrong in blood cancers and other disorders.

November 18, 2022

Response to Vaccination in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Dr. Susan Leclair has reviewed three abstracts from the 2021 American Society of Hematology Annual Meeting and Exposition, or ASH 2021, on chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) patients’ responses to vaccines, two on the COVID-19 vaccine, and one on the shingles vaccines.

November 18, 2022

ASH 2021: Effect of Bruton Tyrosine Kinase Inhibitor on Serologic and Cellular Immune Responses to Recombinant Herpes Zoster Vaccine

As one ages, the risk of reactivating the zoster virus and developing a painful outbreak of shingles increases. While chickenpox was bad enough when you were a child, the adult form of herpes zoster or shingles can be much worse.

September 1, 2022

ASH 2021: Dr. Brian Koffman on Awareness, Knowledge, and Preferences of Patients with Chronic Lymphocytic Leukemia (CLL) and Their Caregivers Related to Finite Duration Therapy and Measurable Residual Disease

At the American Society of Hematology (ASH) 2021, Dr. Sameer Parikh, a hematologist and oncologist at the Mayo Clinic in Rochester, MN, interviewed our own Dr. Brian Koffman, Executive Vice President and Chief Medical Officer of the CLL Society. They discussed results from a survey of patients and caregivers.

August 25, 2022

ASCO 2022: Incidence, Predictors, and Outcomes of Cardiovascular Events in Patients with Chronic Lymphocytic Leukemia

CLL patients are at higher risk for several types of cardiac events and have higher rates of in-hospital mortality, regardless of why they were admitted. In addition, this trial was seriously flawed as it did not address what CLL treatments were used. We know certain therapies such as BTKi,

August 8, 2022

Chronic Lymphocytic Leukemia: 2022 Update on Diagnostic and Therapeutic Procedures

CLL care changes fast. Doctors Hallek and Al-Sawaf are among the best to take on the task of documenting the latest as of October 2021 in this lengthy encyclopedic overview full of solid data and historical references. It was published for physicians in the American Journal of Hematology, not for

July 27, 2022

Q&A with Dr. Josh Hill on Monkeypox

In this interview, our own Dr. Brian Koffman spoke with Dr. Joshua Hill, an infectious disease specialist at the Fred Hutchinson Cancer Center in Seattle, WA, about monkeypox and the current outbreak. Dr. Hill specializes in the infectious disease care of cancer and other immunocompromised patients.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Newly Diagnosed

Dr. Shahzad Mustafa on What it Means to be Immunocompromised for Patients with CLL/SLL

What Makes Being Diagnosed with CLL So Surprising

EAT THIS, NOT THAT! Signs There May Be Something Wrong with Your Blood, Including Weight Loss

Response to Vaccination in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

ASH 2021: Effect of Bruton Tyrosine Kinase Inhibitor on Serologic and Cellular Immune Responses to Recombinant Herpes Zoster Vaccine

ASH 2021: Dr. Brian Koffman on Awareness, Knowledge, and Preferences of Patients with Chronic Lymphocytic Leukemia (CLL) and Their Caregivers Related to Finite Duration Therapy and Measurable Residual Disease

ASCO 2022: Incidence, Predictors, and Outcomes of Cardiovascular Events in Patients with Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia: 2022 Update on Diagnostic and Therapeutic Procedures

Q&A with Dr. Josh Hill on Monkeypox

CLL SOCIETY FAST FIND

QUICK LINKS

ABOUT US

CONTACT